The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s MRNA supplemental Biologics License Application (sBLA) for Spikevax, the company's COVID-19 vaccine, in children six months thro
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the co
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 /
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run
Major U.S. equities indexes finished the day mixed as investors worked through the latest developments in the trade policy saga.
MRNY's synthetic option strategy delivers high distributions but has led to severe capital losses, with price down over 83% in the past year. The capped upside and unlimited downside risk make MRNY un

2 Beaten-Down Stocks to Buy and Hold

07:45am, Saturday, 05'th Jul 2025
Equity markets have been volatile throughout the year. We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

Where Will Moderna Be in 10 Years?

05:10am, Saturday, 05'th Jul 2025
A lot can happen in 10 years, and that's good news for a struggling stock like Moderna (MRNA 0.66%). Once a stock market star generating billions of dollars in coronavirus vaccine revenue, Moderna in

Why Moderna Stock Was So Healthy This Week

03:07pm, Friday, 04'th Jul 2025
Moderna (MRNA 0.66%), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. Investors piled into its shares ove
Key Points A Reddit user shared how he invested his $1.8 million inheritance, listing the mix of different assets he had selected. Most other posters felt he had a solid mix of different assets, inclu
Moderna rises as CDC expands RSV vaccine guidance to include high-risk adults aged 50-59, boosting mResvia's reach.
Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.
MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.
Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars to grow wealth. But I've got good news for them and for you: You
U.S. equities gained at midday, with the S&P 500 and Nasdaq adding to their all-time highs, on optimism about more U.S. trade deals. The Dow Jones Industrial Average was up as well.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE